VSY Biotechnology GmbH
DE-MF-000025210 · Germany · Leinfelden-Echterdingen
VSY Biotechnology GmbH is registered in the European database on medical devices as a manufacturer, with 131 devices declared. It was not found in the U.S. FDA device establishment register.
What this manufacturer declares
| Class IIb | 131 |
|---|
Among these devices, 131 are declared sterile, 131 implantable.
Devices declared under this manufacturer
- ACRIVA
- ACRIVA UD
Showing 12 of 131 declared devices.
Catalogue references include ACRIVA UD 613, M031G.
European nomenclature codes declared: P030199.
United States market access
| FDA establishment register | Not found in the FDA register |
|---|---|
| Devices in EUDAMED | 131 |
| Country of registration | Germany |
⚠️ Not found is not the same as not sold — how this comparison can be wrong.
Device-level evidence
| Devices with a numeric GTIN | 131 |
|---|---|
| Found in the U.S. device database | 0 |
| Share | 0.0 % |
Canadian market access
| Health Canada licence listing | Licensed in Canada |
|---|---|
| Matched entry | VSY BIOTECHNOLOGY GMBH |
What it holds in Canada
| Licences on record | 1 |
|---|---|
| Currently active | 0 |
| Class 3 devices | 1 |
| First licensed | 2024-03-01 |
Licence types: Single Device (1).
Licensed under: REVISCON MONO 2.0%.
North American profile: Canada only. VSY Biotechnology GmbH holds a Canadian licence but was not found in the U.S. register.